Michael H. Ieong, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Pulmonary, Allergy, Sleep & Critical Care Medicine

MD, University of Illinois
BA, Oberlin College



Dr. Ieong is an Assistant Professor in the Department of Medicine. He attends in the Medical Intensive Care Unit and on the Pulmonary Consult service of Boston Medical Center. He sees patients in the Pulmonary and Allergy outpatient clinic and oversees the cardiopulmonary exercise testing program.

Dr. Ieong's focus is on translational medicine. His research focuses on the innate immunity of the lung in response to infection, particularly in the context of immune compromise such as HIV-infection. His clinical expertise is in critical care medicine and the administration of intensive care units.

Dr. Ieong is a NIH-funded Principal Investigator with research focused on the role of the alveolar macrophage and monocyte in host immunity and HIV-related lung pathogenesis. Projects in the lab study the redox regulation of HIV expression in alveolar macrophages; the role of IL-16 in HIV-infection of alveolar macrophages; and, HIV-induced impairment of alveolar macrophage handling of C. neoformans. He is an experienced research bronchoscopist and collaborates with a number of investigators to provide primary lung cells and lavage for study. He is a member of the Pulmonary Immunology Group and the Center for HIV/AIDS Care and Research.

Research special interests include:
-HIV pathogenesis in the lung
-Redox cell signaling pathways
-Alveolar macrophage biology
-Innate immunity of the lung

Clinical special interests include:
-HIV-related lung disease
-General pulmonary medicine
-Exercise physiology

Member
Boston University
Pulmonary Center




Redox Regulated HIV Expression in Alveolar Macrophages
08/15/2003 - 11/30/2008 (PI)
NIH/National Heart, Lung, and Blood Institute
5 K08 HL73671 05


COVID-PACT A Multicenter, Randomized-Controlled Trial to Evaluate the Efficacy and Safety of Antithrombotic Therapy for Prevention of Arterial and Venous Thrombotic Complications in Critically-Ill COVID-19 Patients
09/14/2020 - 09/13/2023 (PI)
Brigham and Womens Hospital

ECU-COV-401: SOLIRIS® (eculizumab) for the Treatment of Participants with Coronavirus Disease 2019 (COVID-19) – An Expanded Access Program for Hospital-based Emergency Treatment.
06/16/2020 - 06/15/2023 (PI)
Alexion Pharmaceuticals

ALXN1210-COV-305: A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute R
06/08/2020 - 06/07/2023 (PI)
Alexion Pharmaceuticals


Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Bohula EA, Berg DD, Lopes MS, Connors JM, Babar I, Barnett CF, Chaudhry SP, Chopra A, Ginete W, Ieong MH, Katz JN, Kim EY, Kuder JF, Mazza E, McLean D, Mosier JM, Moskowitz A, Murphy SA, O'Donoghue ML, Park JG, Prasad R, Ruff CT, Shahrour MN, Sinha SS, Wiviott SD, Van Diepen S, Zainea M, Baird-Zars V, Sabatine MS, Morrow DA. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT. Circulation. 2022 Nov; 146(18):1344-1356. PMID: 36036760; DOI: 10.1161/CIRCULATIONAHA.122.061533;
     
  2. Bosch NA, Crable EL, Ackerbauer KA, Clark K, Drainoni ML, Grim V, Ieong MH, Walkey AJ, Murphy J. Implementation of a Phenobarbital-based Pathway for Severe Alcohol Withdrawal: A Mixed-Method Study. Ann Am Thorac Soc. 2021 10; 18(10):1708-1716.View Related Profiles. PMID: 33945771
     
  3. Nadjarian A, LeClair J, Mahoney TF, Awtry EH, Bhatia JS, Caruso LB, Clay A, Greer D, Hingorani KS, Horta LFB, Ibrahim M, Ieong MH, James T, Kulke MH, Lim R, Lowe RC, Moses JM, Murphy J, Nozari A, Patel AD, Silver B, Theodore AC, Wang RS, Weinstein E, Wilson SA, Cervantes-Arslanian AM. Validation of a Crisis Standards of Care Model for Prioritization of Limited Resources During the Coronavirus Disease 2019 Crisis in an Urban, Safety-Net, Academic Medical Center. Crit Care Med. 2021 10 01; 49(10):1739-1748.View Related Profiles. PMID: 34115635; DOI: 10.1097/CCM.0000000000005155;
     
  4. Burgess CM, Batchelder AW, Sloan CA, Ieong M, Streed CG. Impact of the COVID-19 pandemic on transgender and gender diverse health care. Lancet Diabetes Endocrinol. 2021 11; 9(11):729-731.View Related Profiles. PMID: 34570996; DOI: 10.1016/S2213-8587(21)00266-7;
     
  5. Garcia MA, Rampon GL, Doros G, Jia S, Jagan N, Gillmeyer K, Berical A, Hudspeth J, Ieong M, Modzelewski KL, Schechter-Perkins EM, Ross CS, Rucci JM, Simpson S, Walkey AJ, Bosch NA. Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 Study Protocol: A Clinical Trial. Ann Am Thorac Soc. 2021 09; 18(9):1560-1566.View Related Profiles. PMID: 33647225; DOI: 10.1513/AnnalsATS.202009-1124SD;
     
  6. Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33.View Related Profiles. PMID: 32721528; DOI: 10.1016/j.ijid.2020.07.023;
     
  7. Stephens AR, Wiener RS, Ieong MH. Comparison of Methods To Identify Advance Care Planning in Patients with Severe Chronic Obstructive Pulmonary Disease Exacerbation. J Palliat Med. 2018 03; 21(3):284-289.View Related Profiles. PMID: 28850288; DOI: 10.1089/jpm.2017.0251;
     
  8. Kozlowski E, Wasserman GA, Morgan M, O'Carroll D, Ramirez NP, Gummuluru S, Rah JY, Gower AC, Ieong M, Quinton LJ, Mizgerd JP, Jones MR. The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses. PLoS One. 2017; 12(6):e0179797.View Related Profiles. PMID: 28665939; DOI: 10.1371/journal.pone.0179797;
     
  9. Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, Ieong M, Mohr C, Lin DY, Buchwald I, Bahhady I, Wengryn J, Maheshwari V, Hill NS. Use and Outcomes of Noninvasive Ventilation for Acute Respiratory Failure in Different Age Groups. Respir Care. 2016 Jan; 61(1):36-43. PMID: 26374908
     
  10. Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, Ieong M, Mohr C, Lin DY, Buchwald I, Bahhady I, Wengryn J, Maheshwari V, Hill NS. Where is Noninvasive Ventilation Actually Delivered for Acute Respiratory Failure? Lung. 2015 Oct; 193(5):779-88. PMID: 26210474
     
Showing 10 of 21 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 21 publications over 12 distinct years, with a maximum of 4 publications in 2021

YearPublications
19991
20001
20021
20062
20082
20101
20142
20153
20172
20201
20214
20221
Contact for Mentoring:

72 E. Concord St Housman (R)
Boston MA 02118
Google Map


Ieong's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department